Elbit Systems Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ESLT research report →
Range $790 – $850
Price Chart
About the company
Established in Haifa, Israel, in 1966, Elbit Systems Ltd. is a leading provider of comprehensive defense, homeland security, and commercial aviation solutions. The company designs and manufactures an extensive portfolio of advanced systems tailored for air, land, and naval applications.
- CEO
- Bezhalel Machlis
- IPO
- 1996
- Employees
- 21,000
- HQ
- Haifa, HA, IL
AI snapshot
Six angles, distilled from the data.
The stock is in a broad corrective regime after a major run, still below its 200-day average and well off the 52-week high. That leaves the setup more like a recovery attempt than a confirmed long-term uptrend, even after the recent rebound from the lower end of the yearly range.
Street sentiment is constructive but cautious: the consensus is Hold, with 5 Holds and 1 Buy. The target cluster has drifted down to $820 from earlier, while recent Jefferies and Morgan Stanley updates kept targets in the $790-$850 range, signaling support but less upside enthusiasm.
Execution has been strong, with 7 straight EPS beats and the last four surprises ranging from 11.5% to 26.7%. Next-year EPS estimates continue to rise toward $18.61, so shareholders should watch whether revenue growth and margin discipline can keep pace with elevated expectations.
The pattern is net selling, led by executive vice presidents trimming shares while several M-exempt and F-InKind entries reflect award and vesting mechanics. The only clear discretionary sale in the table is Shmuely Yoram’s 7,654-share sale, with similar sale activity from Vered Yehuda and Oren Sabag.
Profitability is solid for defense: gross margin is 25.0%, operating margin 9.4%, and net margin 7.44%. Growth remains healthy with revenue up 15.9% year over year and earnings up 34.2%, while free cash flow of $1.00 billion and $815.9 million of cash leave the balance sheet workable despite modest net debt.
Elbit sits in the stronger end of aerospace and defense on growth and cash generation, but the valuation is rich at 49.2x earnings. That premium leaves less room for disappointment versus peers, even with a negative beta and a steady earnings beat record.
- Market Cap
- $30.75B
- P/E
- 45.54
- Fwd P/E
- 43.26
- PEG
- 0.99
- P/S
- 3.53
- P/B
- 6.82
- EV/EBITDA
- 30.95
- Div Yield
- 0.51%
- Gross Margin
- 25.14%
- Op Margin
- 9.45%
- Net Margin
- 7.67%
- ROE
- 15.72%
- ROIC
- 9.12%
Latest fiscal year · YoY change
- Revenue
- $7.94B+16.3%
- Gross Profit
- $1.94B+17.9%
- Op Income
- $687.18M
- Net Income
- $534.34M+66.4%
- EPS
- $11.69+61.9%
- OCF Growth
- +45.6%
- FCF Growth
- +73.0%
- 52W High
- $1016.06
- 52W Low
- $453.00
- 50D MA
- $720.84
- 200D MA
- $785.13
- Beta
- -0.23
- RSI (14)
- 40
- Avg Volume
- 86.46K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Elbit delivered strong Q3 2026 growth with higher margins, record backlog, and a confident 2027 outlook for high-teens revenue growth.· November 17, 2026
- Revenue rose 17.2% year over year to $2.252 billion, with GAAP diluted EPS up 32% to $3.70.
- GAAP gross margin improved to 25.3% and GAAP operating margin rose to 10.3%; non-GAAP operating margin reached 10.8%.
- Free cash flow was $276 million in the quarter, with cash conversion above 150%, and nine-month operating cash flow reached $862.5 million.
- Backlog hit a record $33 billion, up $7.8 billion year over year and $1 billion sequentially, giving management strong visibility.
- Management said 2027 should see high-teens revenue growth and continued margin expansion versus full-year 2026.
Third quarter 2026 revenue increased 17.2% year over year to $2.252 billion versus $1.922 billion in Q3 2025. GAAP gross margin was 25.3% versus 24.9% a year ago; non-GAAP gross margin was 25.7% versus 25.2%. GAAP operating income was $233 million, or 10.3% of revenue, versus $171 million, or 8.9%, and non-GAAP operating income was $244 million, or 10.8% of revenue, versus $187 million, or 9.7%. GAAP diluted EPS was $3.70 versus $2.80, and non-GAAP diluted EPS was $4.36 versus $3.35. Free cash flow was $276 million in Q3 versus $101 million a year ago, and operating cash flow for the first nine months was $862.5 million versus $461 million. Backlog ended at a record $33 billion, up $7.8 billion year over year and $1 billion sequentially. Management guided to high-teens revenue growth and continued margin expansion in 2027 compared with full-year 2026; it also declared a $1 per share dividend payable January 4, 2027.
The CEO framed the quarter as another period of strong execution, saying Elbit is converting substantial demand into growth, profitability, and new business. He emphasized the $33 billion backlog, ongoing investment in production capacity and automation, and progress in high-power laser programs, including the Sting helicopter-mounted prototype and the XCalibur pod-based solution. His tone was confident and operationally focused, with repeated emphasis on disciplined execution and long-term value creation.
The CFO highlighted broad-based financial improvement: revenue up 17.2%, GAAP gross margin at 25.3%, GAAP operating income of $233 million, and GAAP EPS of $3.70. He pointed to free cash flow of $276 million and cash conversion above 150%, helped by stronger net income and higher contract liabilities, and noted that lower financial expenses reflected strong cash generation and reduced average debt. He also said CapEx investment increased from around $220 million to $300 million over the last 12 months, and that some customers are now financing facilities, which is helping reduce Elbit’s own capital burden.
Analysts focused on why sales were flatter sequentially in most regions and whether supply chain or internal throughput was limiting faster backlog conversion. Management said sequentially only Latin America stood out, but they do not see major supply chain or execution constraints and believe they have increased capacity enough to deliver commitments. Questions on 2027 growth and margin expansion were answered with a mix of segment drivers—Land, ISTAR, C4I, and maritime—and a margin story centered on operating leverage, R&D programs moving into production, and selective pricing power from a large, high-margin backlog. CapEx was also a topic, and management said customer-financed facilities are becoming more common and lowering Elbit’s required spend.
The bull case from this call is that demand remains very strong and visible, with a record $33 billion backlog and multiple new awards across Europe, Asia-Pacific, Israel, and maritime. Management is also seeing margin expansion, strong cash generation, and new production capacity coming online, while 2027 guidance points to continued high-teens growth and further margin improvement.
The main risks discussed were that sequential sales growth was uneven and most geographies were flat quarter over quarter, suggesting conversion may not accelerate everywhere at once. Aerospace was described as relatively flattish compared with other segments, and the higher effective tax rate from OECD Pillar II rules could weigh on future earnings. Management’s growth and margin outlook also depends on continued execution on capacity expansion, backlog conversion, and program ramp-ups such as high-power laser and PULS.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 58.7%
- Shares Outstanding
- 46.88M
- Float Shares
- 27.53M
of shares held by institutions
409 13F filers
Congressional trading
Senate and House stock disclosures for ESLT, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Alan ArmstrongSenate | Buy | Mar 30, 26 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Clal Insurance Enterprises Holdings Ltd | 1.62M | ▼ 55 |
| Vanguard Group Inc | 998.27K | ▲ 13.41K |
| Vanguard Capital Management LLC | 764.95K | ▲ 5.75K |
| Van Eck Associates Corp | 565.23K | ▲ 17.55K |
| Y.D. More Investments Ltd | 504.79K | ▲ 21.05K |
| Altshuler Shaham Ltd | 497.76K | ▲ 14.07K |
| Phoenix Financial Ltd. | 390.43K | 0 |
| Invesco Ltd. | 350.95K | ▼ 71.73K |
| Mirae Asset Global Etfs Holdings Ltd. | 302.51K | ▼ 18.21K |
| Harel Insurance Investments & Financial Services Ltd. | 274.77K | ▼ 10 |
| Vanguard Fiduciary Trust Co | 247.75K | ▲ 4.20K |
| Bank Of America Corp | 202.14K | ▲ 19.97K |
Held by 56 ETFs
Biggest fund positions in ESLT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 5, 26 | Bar-Nathan Abudi Jacob | other | 0 |
| Apr 12, 26 | Cohen Boaz | other | 0 |
| Apr 12, 26 | Cohen Boaz | other | 0 |
| Apr 9, 26 | Shmuely Yoram | other | 9,000 |
| Apr 9, 26 | Shmuely Yoram | other | 1,346 |
| Apr 9, 26 | Shmuely Yoram | sell | 7,654 |
| Apr 9, 26 | Shmuely Yoram | other | 9,000 |
| Apr 9, 26 | Vered Yehuda | other | 7,000 |
| Apr 9, 26 | Vered Yehuda | other | 1,047 |
| Apr 9, 26 | Vered Yehuda | other | 7,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ESLT coverage
Recent articles, reports, and earnings notes.

Elbit Systems (ESLT): Backlog-Driven Defense Growth
Elbit Systems posted strong revenue and EPS growth, backed by a record $32.0B backlog and improving cash generation. The stock still trades at a demanding valuation, so the Buy case depends on execution and continued defense demand.

Biomimix, Inc. Repositions Into Defense: What Investors Should Watch
Biomimix, Inc. (NASDAQ: BMMX) is expected to list on 2026-10-15, but the price range has not been disclosed yet. The company’s filing points to a business pivot into defense, security, and critical infrastructure technologies rather than a traditional IPO story. Watch for whether investors buy the transformation narrative or focus on the cash burn and customer concentration.

Elbit Systems (ESLT): Backlog Growth vs. Rich Valuation
Elbit Systems is posting strong revenue and EPS growth, backed by a $30.2B backlog and demand in land systems, EW, and C4I. The stock still screens expensive, so the report lands on a Hold despite solid execution.
Want a deeper read on ESLT?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Elbit Systems Ltd. (ESLT) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 17
What Elbit Systems (ESLT) Said on Its Q3 Earnings Call
marketbeat.com · Nov 17
Compared to Estimates, Elbit (ESLT) Q3 Earnings: A Look at Key Metrics
zacks.com · Nov 17
Elbit Systems: Strong Growth, Expensive Stock
seekingalpha.com · Nov 17
Elbit Systems (ESLT) Surpasses Q3 Earnings Estimates
zacks.com · Nov 17
ELBIT SYSTEMS REPORTS THIRD QUARTER 2026 RESULTS
gurufocus.com · Nov 17
ELBIT SYSTEMS REPORTS THIRD QUARTER 2026 RESULTS
prnewswire.com · Nov 17
Buy 4 Drone Technology Bigwigs to Enhance Your Portfolio Returns
zacks.com · Nov 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 17, 2026 · Live quote · Not investment advice